According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 12,00ย โฌ. In 2016 the company made an earnings per share (EPS) of -10,59ย โฌ an increase over its 2015 EPS that were of -11,43ย โฌ.